European Academy of Neurology/Movement Disorder Society ‐ European Section guideline on the treatment of Parkinson's disease: I. Invasive therapies
Günther Deuschl(Christian-Albrechts-Universität zu Kiel), Elena Moro(Inserm), Giovanni Fabbrini(Istituto Neurologico Mediterraneo), Joaquim J. Ferreira(University of Lisbon), Pablo Mir(Hospital Universitario Virgen del Rocío), Katarzyna Śmiłowska(Christian-Albrechts-Universität zu Kiel), Nicholas Henschke(Cochrane), Gemma Villanueva(Cochrane), Angelo Antonini(University of Padua), Evžen Růžička(Charles University), Anette Schrag(National Hospital for Neurology and Neurosurgery), Pille Taba(Tartu University Hospital), Klaus Seppi(Innsbruck Medical University), João Costa(University of Lisbon), Daniela Berg(Christian-Albrechts-Universität zu Kiel), Marianna Selikhova(Southmead Hospital), Jean‐Christophe Corvol(Centre National de la Recherche Scientifique)
Cited by 106
Related Papers
MDS clinical diagnostic criteria for Parkinson's disease
|Movement Disorders|2015|7.4k
Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria
|Movement Disorders|2017|2.3k
Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
|New England Journal of Medicine|2009|2.1k
Genome-wide association study reveals genetic risk underlying Parkinson's disease
|Nature Genetics|2009|2k
Neurostimulation for Parkinson's Disease with Early Motor Complications
|New England Journal of Medicine|2013|1.4k